Stock INTEG B INTEGRUM AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Integrum AB

Equities

INTEG B

SE0009807266

Medical Equipment, Supplies & Distribution

Delayed Nasdaq Stockholm
Other stock markets
 05:00:03 2024-05-15 am EDT 		5-day change 1st Jan Change
56.4 SEK +2.55% Intraday chart for Integrum AB +9.69% +23.99%
May. 02 Integrum Expands Its Product Offering to the United Kingdom Market CI
Mar. 26 Integrum Enters a Commercial agreement with AMI Technologies to introduce the OPRATM Implant System in Israel CI

Valuation

Fiscal Period: Abril 2021 2022 2023 2024 2025 2026
Capitalization 1 871.1 757.6 476.3 1,014 - -
Enterprise Value (EV) 1 871.1 682.5 434.4 991.8 995.1 969.2
P/E ratio - 35.9 x -131 x 1,375 x 73.7 x 41.7 x
Yield - - - - - -
Capitalization / Revenue 16.4 x 9.88 x 6.41 x 9.47 x 6.71 x 4.68 x
EV / Revenue 16.4 x 8.9 x 5.85 x 9.27 x 6.59 x 4.47 x
EV / EBITDA - 296 x -23.4 x 140 x 55.9 x 30.1 x
EV / FCF - -13.7 x -40.8 x -53 x -71.1 x 57 x
FCF Yield - -7.28% -2.45% -1.89% -1.41% 1.75%
Price to Book - - - 6.77 x 6.29 x 5.46 x
Nbr of stocks (in thousands) 15,838 18,038 18,215 18,435 - -
Reference price 2 55.00 42.00 26.15 55.00 55.00 55.00
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: Abril 2021 2022 2023 2024 2025 2026
Net sales 1 53.01 76.68 74.27 107 151 216.6
EBITDA 1 - 2.303 -18.55 7.093 17.81 32.24
EBIT 1 - 1.039 -19.7 4.983 17.25 36.77
Operating Margin - 1.35% -26.53% 4.66% 11.42% 16.97%
Earnings before Tax (EBT) 1 - 1.185 -21.52 4.96 17.31 29.78
Net income 1 -0.6017 21.27 - 3.713 15.35 23.24
Net margin -1.14% 27.74% - 3.47% 10.17% 10.73%
EPS 2 - 1.170 -0.2000 0.0400 0.7467 1.320
Free Cash Flow 1 - -49.66 -10.66 -18.7 -14 17
FCF margin - -64.76% -14.35% -17.47% -9.27% 7.85%
FCF Conversion (EBITDA) - - - - - 52.73%
FCF Conversion (Net income) - - - - - 73.15%
Dividend per Share 2 - - - - - -
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: April 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1 2025 Q2 2025 Q3 2025 Q4
Net sales 1 15.21 20.47 25.07 25.18 32.4 22.11 18.13 20.4 27.56 30.11 29.2 31.7 35.8 40.55 42
EBITDA 1 - - - - - - - - - - - 2 4 5 5
EBIT 1 -0.243 0.503 -0.468 0.366 0.873 -13.77 -7.171 -2.925 6.454 0.34 1.95 3.5 3.95 5.15 5
Operating Margin -1.6% 2.46% -1.87% 1.45% 2.69% -62.3% -39.55% -14.34% 23.42% 1.13% 6.68% 11.04% 11.03% 12.7% 11.9%
Earnings before Tax (EBT) 1 - 0.541 -0.317 - - - - - - - -1 2 3 4 5
Net income 1 - 0.532 3.273 - - - - - - - -1 1 2 3 4
Net margin - 2.6% 13.06% - - - - - - - -3.42% 3.15% 5.59% 7.4% 9.52%
EPS 2 - - - - - - - - - - -0.0400 0.0800 0.1400 0.2000 0.2100
Dividend per Share - - - - - - - - - - - - - - -
Announcement Date 12/2/21 3/2/22 6/10/22 8/31/22 12/1/22 3/1/23 6/8/23 8/31/23 12/4/23 2/29/24 - - - - -
1SEK in Million2SEK
Estimates

Balance Sheet Analysis

Fiscal Period: April 2021 2022 2023 2024 2025 2026
Net Debt 1 - - - - - -
Net Cash position 1 - 75.1 41.9 22.1 18.8 44.8
Leverage (Debt/EBITDA) - - - - - -
Free Cash Flow 1 - -49.7 -10.7 -18.7 -14 17
ROE (net income / shareholders' equity) - 23.1% -2.46% 0.4% 3.74% 7.07%
ROA (Net income/ Total Assets) - - - - - -
Assets 1 - - - - - -
Book Value Per Share 2 - - - 8.120 8.740 10.10
Cash Flow per Share - - - - - -
Capex 1 - 29.3 11.4 5.3 5.75 12.3
Capex / Sales - 38.17% 15.35% 4.95% 3.81% 5.68%
Announcement Date 5/31/21 6/10/22 6/8/23 - - -
1SEK in Million2SEK
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Ratings for Integrum AB

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Medical Prosthetics

1st Jan change Capi.
INTEGRUM AB Stock Integrum AB
+23.99% 93.71M
STRAUMANN HOLDING AG Stock Straumann Holding AG
-10.91% 21.11B
SONOVA HOLDING AG Stock Sonova Holding AG
+5.98% 18.8B
COCHLEAR LIMITED Stock Cochlear Limited
+11.12% 14.12B
DEMANT A/S Stock Demant A/S
+9.32% 10.2B
EYEBRIGHT MEDICAL TECHNOLOGY (BEIJING) CO., LTD. Stock Eyebright Medical Technology (Beijing) Co., Ltd.
-11.30% 2.22B
EMBLA MEDICAL HF. Stock Embla Medical hf.
+5.65% 1.78B
ANGELALIGN TECHNOLOGY INC. Stock Angelalign Technology Inc.
+34.04% 1.64B
MODERN DENTAL GROUP LIMITED Stock Modern Dental Group Limited
+24.42% 648M
ANGEL ROBOTICS CO., LTD. Stock Angel Robotics Co., Ltd.
0.00% 394M
Medical Prosthetics
  1. Stock Market
  2. Equities
  3. INTEG B Stock
  4. Financials Integrum AB
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW